For Company Research, enter symbol or keyword and choose type of research:    Symbol Search
JP Morgan Chase & CO
(NYSE: JPM) Add to Portfolio
$109.68
+0.24 (+0.22%)
as of 09:47 EDT

Today, StatPro Group plc, ("StatPro", "the Group", AIM: SOG), the AIM listed provider of cloud-based portfolio analytics and asset pricing services for the global asset management industry, and the Corporate and Investment Bank of (full story)
JPM: 109.68 (+0.24)
Wall Street finished a milestone-setting week on a downbeat note Friday after a late flurry of selling nudged stocks lower, ending the market's four-day winning streak. (full story)
HUM: 267.26 (-2.95), C: 68.39 (+0.42), WFC: 46.57 (-0.32), JPM: 109.68 (+0.24), UNH: 250.69 (-1.59)
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company that is pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced the closing of its initi (full story)
JPM: 109.68 (+0.24), STOK: 26.48 (-0.81)
ALEXANDRIA, Va. (AP) — Walmart agreed Thursday to pay $282 million to settle federal allegations of overseas corruption, including funneling more than $500,000 to an intermediary in Brazil who was known as a "sorceress" for (full story)
PCRFY: 8.1800 (unch), JPM: 109.68 (+0.24), WMT: 111.71 (+0.58)
InvestorsObserver issues critical PriceWatch Alerts for ARRY, JPM, KO, MTCH, and NFLX. (full story)
NFLX: 373.62 (+4.41), KO: 51.88 (+0.33), ARRY: 46.29 (+0.09), JPM: 109.68 (+0.24), MTCH: 69.23 (+2.44)
SOURCE: Chase Card Services and Southwest Airlines (full story)
JPM: 109.68 (+0.24), LUV: 51.27 (+0.02)
Akero Therapeutics, Inc. (NASDAQ: AKRO), a clinical-stage biotechnology company developing transformational treatments for people with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced the (full story)
JPM: 109.68 (+0.24), AKRO: 19.96 (+0.26)
Newpark Resources, Inc. (NYSE: NR) announced that its management team will present at the J.P. Morgan Energy Equity Investor Conference to be held on June 18-19, 2019 in New York City. (full story)
NR: 7.05 (+0.01), JPM: 109.68 (+0.24)
Helmerich & Payne, Inc. (NYSE:HP) today announced that Mary M. VanDeWeghe was appointed to the Company's Board of Directors effective June 5, 2019. With Ms. VanDeWeghe's appointment, Helmerich & Payne's Board (full story)
JPM: 109.68 (+0.24), BEAV: 64.47 (-0.44), HP: 50.95 (-0.16), ECL: 190.69 (+1.10)
J.P. Morgan's focus and investments in global e-commerce payments are paying off with multiple top rankings from the Nilson Report and the Strawhecker Group. (full story)
JPM: 109.68 (+0.24)
 
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. SEC Filings provided by Edgar Online. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.